The biocatalysis discipline has the potential to generate important chiral organic compounds by the use of enzymes, usually in the presence of critical co-factors. [1, 2] Therefore, practical methods for the regeneration of the co-enzyme, 1,4-NADH, have continued to be of significance in the biocatalysis field. [3] [4] [5] In this vain, a variety of transition metal hydrides have been evaluated as catalysts for the regioselective reduction of NAD + and NAD + models to the corresponding 1,4-NADH derivatives in order to attempt to develop faster rates and a more economical regeneration process. [6] [7] [8] [9] In the most significant example, Steckhan and co-workers have described the use of in situ generated [Cp*Rh(bpy)(H)] + (Cp* = η 5 -C 5 Me 5 , bpy = 2,2'-bipyridyl), for the regiospecific reduction of natural NAD + to 1,4-NADH, [7] and then demonstrated the co-factor regeneration process in
horse liver alcohol dehydrogenase enzymatic, chiral reduction reactions. [10] [11] [12] More importantly, we recently reported on the source of this unusually high regioselectivity for 1,4-NADH and other mechanistic aspects with a model NAD + compound, 1-benzylnicotinamide triflate, 1, in 1:1 H 2 O/THF using [Cp*Rh(bpy)(H 2 O)](OTf) 2 , 2, as the catalyst precursor, and sodium formate as the hydride source to exclusively provide the kinetic product, 1-benzyl-1,4-dihydronicotinamide, 3. [13] In addition, we also recently utilized an aqueous NAD + model, β-nicotinamide-5'-ribose methyl phosphate, 4, and demonstrated its similar regioselective reduction with in situ formed [Cp*Rh(bpy)(H)] + to the corresponding 1,4dihydronicotinamide-5'-ribose methyl phosphate, 5, at pH 6.5. [14] It is important to note that NAD + model, 4, has some structural similarities to NAD + , with particular emphasis on the mono-ribose phosphate moiety, but with no pyrophosphate nor adenosine substituents, while also recognizing that the structure of the NAD + biomimic, 1, has a simple 1-benzyl group in place of the ribose, pyrophosphate, and adenosine groups. The initial rates (r i ) of the regioselective reduction of both 1 in 4:1 H 2 O/THF and 4 in H 2 O at pH 6.5, with in situ generated [Cp*Rh(bpy)(H)] + , to their corresponding 1,4-dihydro analogs, 3 and 5, were comparable to NAD + in H 2 O at pH 6.5 (turnover frequency [TOF], 20 h -1 ). [14] Therefore, we decided to attempt to use both 1 and 4 as biomimics of NAD + in chiral reduction reactions, in conjunction with the above-mentioned co-factor regeneration method. [13, 14] Moreover, recent studies with other NAD + biomimics by Lowe and co-workers showed that the oxidation of primary alcohols to aldehydes occurred, along with 1,4-NADH biomimic production, but the reverse reaction, i.e., the reduction of aldehydes to alcohols, along with NAD + biomimic production, was not observed. [15] [16] [17] Thus, the pertinent question we asked ourselves was:
what is the role of each substituent on the 1,4-dihydronicotinamide nucleus, including ribose, pyrophosphate, and adenosine groups, and will HLADH enzymatic recognition at the binding site for the co-factor prevail to provide chiral reduction products with the most important structural feature still present in our biomimetic 1,4-NADH models; namely, the 1,4-dihydronicotinamide nucleus? [18] [19] [20] [21] The preliminary, tandem co-factor regeneration and chiral synthesis experiments with substrates 6-10 (Chart) and NAD + A structure-reactivity study (Chart) of a variety of ketone substrates ( Alternatively, the bulky, aliphatic ketone, norcamphor, 10, which is actually a commercial mixture of two enantiomers, reacted at not only different reduction rates, but also provided a different diastereomeric mixture of predominantly endo chiral alcohols. As shown in Table 2 , one enantiomer of 10 gave an approximately equal mixture of the exo and endo alcohols, while the other gave exclusively the endo-alcohol with no exo-alcohol detected.
Interestingly, the hydride transfer pathway from 1,4-NADH to the HLADH bound ketone is still very controversial, with various mechanisms proposed, but none appear very satisfactory. [22] The previously formulated results indicated that the initial binding process of natural 1,4-NADH occurs in proximity to the Zn 2+ metal ion center of HLADH, and the Zn 2+ bound substrate. [23, 24] In a manner similar to that of the [Cp*Rh(bpy)H] + binding of biomimic 1 for regioselective production of 3, [13, 14] we also envision the possibility that the carbonyl of the amide group of 1,4-NADH, and that of biomimics, 3 or 5, might weakly bind to the Zn 2+ metal ion center to stabilize this hydride transfer process. This possible Zn 2+ binding process of co-factor during the transfer of hydride from 5 to the re face of the carbonyl group could also conceivably add stability to the microscopic reverse reaction; i.e., hydride transfer from a specific C-H of RCH 2 OZn to 4, to give a C=O product and 5.
We have in fact shown that the reverse reaction, S-CH -3 CH 2 CH 2 CH(OH)CH 3 to CH 3 CH 2 CH 2 C(O)CH 3 , 9, occurs with NAD + biomimic, 4, while the R-enantiomer was found to be extremely slow. While the economic benefits of this discovery can not be fully evaluated at this time for biocatalytic applications, it is obvious from the presented results, and previous observations, [15] [16] [17] that some structural features of 1,4-NADH need not be present to afford enzyme recognition and chiral organic compound synthesis. We hope our results pave the way for the possible utilization of NAD + models, such as 1 and 4, in a variety of biocatalytic processes of industrial importance; model 1 and other potential analogs especially being more stable under conditions that might cause the NAD + to be hydrolytically compromised. [26, 27] [ 
Control Experiments
No chiral alcohol product was formed without the presence of the HLADH enzyme, while no ketone was reduced to alcohol in the presence of the model cofactors, 1 and 4 . 
